FDA Issued Emergency Authorization Of Hydroxychloroquine For Coronavirus Care

Mar 29, 2020

The Food and Drug Administration issued an emergency use authorization for hydroxychloroquine for coronavirus treatment.

Multiple companies are donating millions of doses of hydroxychloroquine.

  • Novartis announced its commitment to donate up to 130 million doses.
  • Amneal pledged to make 20 million tablets by mid-April. 
  • Teva is donating 16 million tablets to hospitals around the U.S.
  • Bayer is donating 3 million doses.

Oracle is working on an online platform designed in collaboration with the White House. When finished, it will be used to collect information about the use of chloroquine and hydroxychloroquine to treat Covid-19, the disease caused by the coronavirus.

Thank You For Reading

Chloroquine — Very Old New Weapon Against Coronavirus

Chloroquine isn’t new. Its use dates back to World War II. Initially created to treat malaria, it is also used today in the treatment of rheumatoid arthritis and lupus.

It appears that this drug prevents the gain of the virus into the cells and, therefore, prevents the cellular infection from occurring.

Roger Seheult, MD. is explaining

The possible efficacy of chloroquine in the treatment of coronavirus infections.

Published by MedCram on Mar 10, 2020

Both the virus that causes SARS and the virus responsible for COVID-19 belong to the same family of coronaviruses. Researchers discovered that the protein spikes on the surface of the SARS virus are similar to the protein spikes found on the surface of the COVID-19 virus.

Given chloroquine’s effectiveness in treating SARS, scientists are studying the effectiveness of the treatment against the new coronavirus responsible for COVID-19. So far, the initial trials are encouraging.

Thank You For Reading